Found: 33
Select item for more details and to access through your institution.
A mosquito AgTRIO mRNA vaccine contributes to immunity against malaria.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00679-x
- By:
- Publication type:
- Article
mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00577-8
- By:
- Publication type:
- Article
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.983000
- By:
- Publication type:
- Article
Rapid and definitive treatment of phenylketonuria in variant-humanized mice with corrective editing.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39246-2
- By:
- Publication type:
- Article
Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37795-0
- By:
- Publication type:
- Article
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-022-35637-z
- By:
- Publication type:
- Article
Innate and Adaptive Immune Parameters following mRNA Vaccination in Mice.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 543, doi. 10.3390/vaccines12050543
- By:
- Publication type:
- Article
Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities.
- Published in:
- Vaccines, 2021, v. 9, n. 12, p. 1490, doi. 10.3390/vaccines9121490
- By:
- Publication type:
- Article
Nanomaterial Delivery Systems for mRNA Vaccines.
- Published in:
- Vaccines, 2021, v. 9, n. 1, p. 65, doi. 10.3390/vaccines9010065
- By:
- Publication type:
- Article
mRNA lipid nanoparticles expressing cell-surface cleavage independent HIV Env trimers elicit autologous tier-2 neutralizing antibodies.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1426232
- By:
- Publication type:
- Article
Immunization with PfGBP130 generates antibodies that inhibit RBC invasion by P. falciparum parasites.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1350560
- By:
- Publication type:
- Article
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 14504, doi. 10.3390/ijms232314504
- By:
- Publication type:
- Article
Antigen Presenting Cell Mimetic Lipid Nanoparticles for Rapid mRNA CAR T Cell Cancer Immunotherapy (Adv. Mater. 26/2024).
- Published in:
- Advanced Materials, 2024, v. 36, n. 26, p. 1, doi. 10.1002/adma.202470201
- By:
- Publication type:
- Article
Antigen Presenting Cell Mimetic Lipid Nanoparticles for Rapid mRNA CAR T Cell Cancer Immunotherapy.
- Published in:
- Advanced Materials, 2024, v. 36, n. 26, p. 1, doi. 10.1002/adma.202313226
- By:
- Publication type:
- Article
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering.
- Published in:
- Advanced Healthcare Materials, 2023, v. 12, n. 30, p. 1, doi. 10.1002/adhm.202301515
- By:
- Publication type:
- Article
Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-04555-1
- By:
- Publication type:
- Article
An ionizable lipid toolbox for RNA delivery.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27493-0
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Journal of Biomedical Materials Research, Part A, 2022, v. 110, n. 5, p. 1, doi. 10.1002/jbm.a.37385
- By:
- Publication type:
- Article
Rational design of anti‐inflammatory lipid nanoparticles for mRNA delivery.
- Published in:
- Journal of Biomedical Materials Research, Part A, 2022, v. 110, n. 5, p. 1101, doi. 10.1002/jbm.a.37356
- By:
- Publication type:
- Article
Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02441-2
- By:
- Publication type:
- Article
Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48555-z
- By:
- Publication type:
- Article
High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45422-9
- By:
- Publication type:
- Article
In situ combinatorial synthesis of degradable branched lipidoids for systemic delivery of mRNA therapeutics and gene editors.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45537-z
- By:
- Publication type:
- Article
In situ combinatorial synthesis of degradable branched lipidoids for systemic delivery of mRNA therapeutics and gene editors.
- Published in:
- Nature Communications, 2024, p. 1, doi. 10.1038/s41467-024-45537-z
- By:
- Publication type:
- Article
Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00901-4
- By:
- Publication type:
- Article
Author Correction: mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Author Correction: mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
TGF-βR2 signaling coordinates pulmonary vascular repair after viral injury in mice and human tissue.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 732, p. 1, doi. 10.1126/scitranslmed.adg6229
- By:
- Publication type:
- Article
Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 662, p. 1, doi. 10.1126/scitranslmed.abq1945
- By:
- Publication type:
- Article
Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach.
- Published in:
- Bioactive Materials, 2024, v. 34, p. 125, doi. 10.1016/j.bioactmat.2023.11.014
- By:
- Publication type:
- Article
A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 7, p. 1483, doi. 10.3390/v15071483
- By:
- Publication type:
- Article
Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 3, p. 540, doi. 10.3390/v14030540
- By:
- Publication type:
- Article
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism.
- Published in:
- Small, 2024, v. 20, n. 11, p. 1, doi. 10.1002/smll.202304378
- By:
- Publication type:
- Article